We are live on ! Find out more
ELTX icon

Elicio Therapeutics
ELTX

47 hedge funds and large institutions have $13.8M invested in Elicio Therapeutics in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.16% less ownership

Funds ownership: 2.34% → 2.18% (-0.16%)

11% less funds holding

Funds holding: 53 → 47 (-6)

32% less capital invested

Capital invested by funds: $20.3M → $13.8M (-$6.48M)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

63% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 19

Holders
47
Holders Change
-6
Holders Change %
-11.32%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
19
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CM
CM Management
Florida
+$764K
2
BCM
Bridgeway Capital Management
Texas
+$282K
3
VFA
Valeo Financial Advisors
Indiana
+$90.3K
4
PFGIA
Patriot Financial Group Insurance Agency
Massachusetts
+$75.6K
5
Renaissance Technologies
Renaissance Technologies
New York
+$73.6K

Top Sellers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
-$718K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$606K
3
NCM
Nantahala Capital Management
Connecticut
-$212K
4
Two Sigma Investments
Two Sigma Investments
New York
-$188K
5
Millennium Management
Millennium Management
New York
-$182K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
26
Steward Partners Investment Advisory
New York
$33K – – –
Deutsche Bank
27
Deutsche Bank
Germany
$29K -$3.16K -140 -9%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$28K – – –
OQS
29
Occudo Quantitative Strategies
Florida
$27K -$2.03K -90 -7%
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$25K +$1.69K +75 +7%
Two Sigma Investments
31
Two Sigma Investments
New York
$23K -$188K -8,321 -89%
AIG
32
American International Group
New York
$23K -$1.72K -76 -7%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$20K -$4.97K -220 -19%
Citigroup
34
Citigroup
New York
$17K -$3.05K -135 -15%
Barclays
35
Barclays
United Kingdom
$15K +$16.1K +715 New
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$12K -$90 -4 -0.7%
Wells Fargo
37
Wells Fargo
California
$10K -$26.3K -1,164 -70%
TRCT
38
Tower Research Capital (TRC)
New York
$10K +$971 +43 +10%
AB
39
Amalgamated Bank
New York
$8K +$8.42K +373 New
AF
40
Amalgamated Financial
New York
$8K +$8.42K +373 New
Legal & General Group
41
Legal & General Group
United Kingdom
$5K – – –
Osaic Holdings
42
Osaic Holdings
Arizona
$5K – – –
AIP
43
Ameritas Investment Partners
Nebraska
$4K – – –
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$3K -$9.17K -406 -75%
Fidelity Investments
45
Fidelity Investments
Massachusetts
$2K +$858 +38 +63%
UBS Group
46
UBS Group
Switzerland
$1K -$18.2K -807 -94%
Federated Hermes
47
Federated Hermes
Pennsylvania
$1K +$790 +35 New
Russell Investments Group
48
Russell Investments Group
United Kingdom
– -$718K -24,809 Closed
Millennium Management
49
Millennium Management
New York
– -$182K -6,264 Closed
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
– -$131K -4,524 Closed
1
2
3

ELTX Hedge Fund Activity: Q1 2022 in Review

47 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q1 2022, worth a combined $13.8M — down 32% from $20.3M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ELTX and 6 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 7 added.

The largest buyer was CM Management, adding an estimated $764K. The largest seller was Russell Investments Group, exiting entirely with an estimated $718K sold.

  • 47 institutional investors held Elicio Therapeutics (ELTX) as of Q1 2022, down from 53 in Q4 2021.
  • Funds reported $13.8M of Elicio Therapeutics stock for Q1 2022, down 32% quarter-over-quarter.
  • 6 funds opened new Elicio Therapeutics positions in Q1 2022 and 12 closed out, a net change of -6 holders.
  • The largest Elicio Therapeutics buyer in Q1 2022 was CM Management, an estimated $764K added.
  • The largest Elicio Therapeutics seller in Q1 2022 was Russell Investments Group, an estimated $718K sold.

Based on aggregated 13F filings for Q1 2022.